Compare DOLE & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOLE | CDNA |
|---|---|---|
| Founded | 1851 | 1998 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2021 | 2007 |
| Metric | DOLE | CDNA |
|---|---|---|
| Price | $14.05 | $28.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $15.00 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 1.1M | 917.0K |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.33 | 0.05 |
| Revenue | ★ $9,172,907,000.00 | $48,324,000.00 |
| Revenue This Year | $4.93 | $16.01 |
| Revenue Next Year | $1.72 | $11.31 |
| P/E Ratio | ★ $42.48 | $583.80 |
| Revenue Growth | 8.23 | ★ 18.93 |
| 52 Week Low | $12.52 | $10.96 |
| 52 Week High | $16.51 | $30.00 |
| Indicator | DOLE | CDNA |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 69.18 |
| Support Level | $13.80 | $14.59 |
| Resistance Level | $14.51 | N/A |
| Average True Range (ATR) | 0.32 | 1.43 |
| MACD | -0.00 | 0.37 |
| Stochastic Oscillator | 53.49 | 85.28 |
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace. Geographically, the company operates in United States, Ireland, U.K. Spain, Sweden, and Others.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.